FAUCI Act
The FAUCI Act (HR 8211) prohibits former top officials from the National Institutes of Health (NIH), Food and Drug Administration (FDA), or Centers for Disease Control and Prevention (CDC) from serving on boards of companies developing drugs, vaccines, or medical devices for eight years after leaving federal service. It also penalizes former officials who profit from drug or device approvals they previously helped determine, with fines up to $250,000 and potential prison time. The bill requires current and future top officials (GS-13 level or higher, or those involved in approvals) to disclose ownership of related patents within 90-180 days. These rules aim to prevent conflicts of interest between federal health regulators and the industries they oversee.
Bill status
in committee
1 of 4 stages cleared
Introduction
May 2024
Committee Review
Floor Vote
President
Introduced May 1, 2024
Last action May 1, 2024
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
May 1, 2024
Committee
Referred to the House Committee on the Judiciary.
lower
May 1, 2024
Introduced
Introduced in House
lower
1 primary · 8 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 8211
Scope: US
Hi! I can help you understand HR 8211. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline